HCPCS code Q2053 — Brexucabtagene car pos t. Status: Active. Effective Apr 1, 2021. Source: CMS HCPCS Level II.

Q2053

Active

Brexucabtagene car pos t

Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Apr 1, 2021
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9391

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
71287-0219-01 Tecartus
71287-0220-01 Tecartus

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2021-Q2
    Brexucabtagene car pos t